Evaluation of a Long-circulating PSMA-targeting Peptide in a Xenograft Model of Bone Metastatic Prostate Cancer.

被引：0
|
作者：
Lo, W. [1 ]
Huang, Y. [1 ]
Chen, M. [1 ]
Lu, A. [1 ]
Wang, S. [1 ]
Chen, L. [1 ]
Farn, S. [1 ]
机构：
[1] Inst Nucl Energy Res, Taoyuan, Taiwan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0029
引用
收藏
页码：S442 / S442
页数：1
相关论文
共 50 条
  • [31] Specific bone region localization of osteolytic versus osteoblastic lesions in a patient-derived xenograft model of bone metastatic prostate cancer
    Hirata, Takeshi
    Park, Seung Chol
    Muldong, Michelle T.
    Wu, Christina N.
    Yamaguchi, Tomonori
    Strasner, Amy
    Raheem, Omer
    Kumon, Hiromi
    Sah, Robert L.
    Cacalano, Nicholas A.
    Jamieson, Catriona H. M.
    Kane, Christopher J.
    Masuda, Koichi
    Kulidjian, Anna A.
    Jamieson, Christina A. M.
    ASIAN JOURNAL OF UROLOGY, 2016, 3 (04) : 229 - 239
  • [32] First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients
    Ruiyue Zhao
    Miao Ke
    Jie Lv
    Shaoyu Liu
    Yuheng Liu
    Jing Zhang
    Lifu Xu
    Di Gu
    Mingzhao Li
    Chao Cai
    Yongda Liu
    Guohua Zeng
    David Alexoff
    Karl Ploessl
    Lin Zhu
    Hank F. Kung
    Xinlu Wang
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1753 - 1762
  • [33] Preliminary evaluation of a novel PSMA-targeting radiopharmaceutical [68Ga]Ga/[177Lu]Lu-NYM032 for theranostic use in prostate cancer
    Fu, Haitian
    He, Huihui
    Wang, Yanjuan
    Li, Wenjin
    Luo, Yihui
    Chen, Liping
    Mi, Yuanyuan
    Sun, Chengwen
    Mao, Yong
    Yu, Chunjing
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, : 1671 - 1684
  • [34] First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients
    Zhao, Ruiyue
    Ke, Miao
    Lv, Jie
    Liu, Shaoyu
    Liu, Yuheng
    Zhang, Jing
    Xu, Lifu
    Gu, Di
    Li, Mingzhao
    Cai, Chao
    Liu, Yongda
    Zeng, Guohua
    Alexoff, David
    Ploessl, Karl
    Zhu, Lin
    Kung, Hank F.
    Wang, Xinlu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (06) : 1753 - 1762
  • [35] First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: Dosimetry and initial evaluation in prostate cancer patients
    Zhao, Ruiyue
    Ke, Miao
    Ploessl, Karl
    Alexoff, David
    Zhu, Lin
    Kung, Hank
    Wang, Xinlu
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [36] Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer
    Murphy, GP
    Troychak, MJ
    Cobb, OE
    Bowes, VA
    Kenny, RJ
    Barren, RJ
    Kenny, GM
    Ragde, H
    Holmes, EH
    Wolfert, RL
    PROSTATE, 1997, 33 (02): : 141 - 146
  • [37] Preclinical Evaluation of a Companion Diagnostic Radiopharmaceutical, [18F]PSMA-1007, in a Subcutaneous Prostate Cancer Xenograft Mouse Model
    Kim, Su Bin
    Song, In Ho
    Kim, Seon Yoo
    Ko, Hae Young
    Kil, Hee Seup
    Chi, Dae Yoon
    Giesel, Frederik L.
    Kopka, Klaus
    Hoepping, Alexander
    Chun, Joong-Hyun
    Park, Hyun Soo
    Yun, Mijin
    Kim, Sang Eun
    MOLECULAR PHARMACEUTICS, 2022, : 1050 - 1060
  • [38] The IGR-CaP1 Xenograft Model Recapitulates Mixed Osteolytic/Blastic Bone Lesions Observed in Metastatic Prostate Cancer
    Al Nakouzi, Nader
    Bawa, Olivia
    Le Pape, Alain
    Lerondel, Stephanie
    Gaudin, Catherine
    Opolon, Paule
    Gonin, Patrick
    Fizazi, Karim
    Chauchereau, Anne
    NEOPLASIA, 2012, 14 (05): : 376 - +
  • [39] The 68Ga / 177Lu-Theragnostic Concept in PSMA-Targeting of Metastatic Castration Resistant Prostate Cancer: Impact of Post-therapeutic Whole Body Scintigraphy in the Follow-Up
    Scarpa, L.
    Maffey-Steffan, J.
    Svirydenka, A.
    Nilica, B.
    Buxbaum, S.
    Mair, C.
    Bektic, J.
    von Guggenberg, E.
    Uprimny, C.
    Horninger, W.
    Virgolini, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S649 - S649
  • [40] Antisense parathyroid hormone-related peptide (PTHrP) inhibits invasion and metastasis and improves survival in a model of metastatic prostate cancer.
    Huang, DC
    Rhim, JS
    Kremer, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S114 - S114
12345